INmune Bio Inc. Announces Third Quarter 2024 Results and Provides Business Update
Provided By GlobeNewswire
Last update: Oct 31, 2024
BOCA RATON, Fla., Oct. 31, 2024 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage inflammation and immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, today announces its financial results for the quarter ended September 30, 2024 and provides a business update.
Read more at globenewswire.com
